The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Etodolac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Etodolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Etodolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Etodolac include Amneal Pharmaceuticals, Genpharm Ulc, Physicians Total Care, Actavis Elizabeth , Blenheim Pharmacal, Teva , Taro Pharmaceuticals , Apotex and PD-Rx Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Etodolac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Etodolac.
Report Scope
The Etodolac market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Etodolac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Etodolac manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amneal Pharmaceuticals
Genpharm Ulc
Physicians Total Care
Actavis Elizabeth
Blenheim Pharmacal
Teva
Taro Pharmaceuticals
Apotex
PD-Rx Pharmaceuticals
Nucare Pharmaceuticals
Eon Labs
Segment by Type
Tablets
Capsules
Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Mild to Moderate Pain
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Etodolac manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Etodolac in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Etodolac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Etodolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Etodolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Etodolac include Amneal Pharmaceuticals, Genpharm Ulc, Physicians Total Care, Actavis Elizabeth , Blenheim Pharmacal, Teva , Taro Pharmaceuticals , Apotex and PD-Rx Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Etodolac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Etodolac.
Report Scope
The Etodolac market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Etodolac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Etodolac manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amneal Pharmaceuticals
Genpharm Ulc
Physicians Total Care
Actavis Elizabeth
Blenheim Pharmacal
Teva
Taro Pharmaceuticals
Apotex
PD-Rx Pharmaceuticals
Nucare Pharmaceuticals
Eon Labs
Segment by Type
Tablets
Capsules
Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Mild to Moderate Pain
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Etodolac manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Etodolac in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Etodolac Market Overview
1.1 Product Overview and Scope of Etodolac
1.2 Etodolac Segment by Type
1.2.1 Global Etodolac Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.3 Etodolac Segment by Application
1.3.1 Global Etodolac Market Value by Application: (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Mild to Moderate Pain
1.3.5 Others
1.4 Global Etodolac Market Size Estimates and Forecasts
1.4.1 Global Etodolac Revenue 2019-2030
1.4.2 Global Etodolac Sales 2019-2030
1.4.3 Global Etodolac Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Etodolac Market Competition by Manufacturers
2.1 Global Etodolac Sales Market Share by Manufacturers (2019-2024)
2.2 Global Etodolac Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Etodolac Average Price by Manufacturers (2019-2024)
2.4 Global Etodolac Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Etodolac, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Etodolac, Product Type & Application
2.7 Etodolac Market Competitive Situation and Trends
2.7.1 Etodolac Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Etodolac Players Market Share by Revenue
2.7.3 Global Etodolac Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Etodolac Retrospective Market Scenario by Region
3.1 Global Etodolac Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Etodolac Global Etodolac Sales by Region: 2019-2030
3.2.1 Global Etodolac Sales by Region: 2019-2024
3.2.2 Global Etodolac Sales by Region: 2025-2030
3.3 Global Etodolac Global Etodolac Revenue by Region: 2019-2030
3.3.1 Global Etodolac Revenue by Region: 2019-2024
3.3.2 Global Etodolac Revenue by Region: 2025-2030
3.4 North America Etodolac Market Facts & Figures by Country
3.4.1 North America Etodolac Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Etodolac Sales by Country (2019-2030)
3.4.3 North America Etodolac Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Etodolac Market Facts & Figures by Country
3.5.1 Europe Etodolac Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Etodolac Sales by Country (2019-2030)
3.5.3 Europe Etodolac Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Etodolac Market Facts & Figures by Country
3.6.1 Asia Pacific Etodolac Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Etodolac Sales by Country (2019-2030)
3.6.3 Asia Pacific Etodolac Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Etodolac Market Facts & Figures by Country
3.7.1 Latin America Etodolac Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Etodolac Sales by Country (2019-2030)
3.7.3 Latin America Etodolac Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Etodolac Market Facts & Figures by Country
3.8.1 Middle East and Africa Etodolac Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Etodolac Sales by Country (2019-2030)
3.8.3 Middle East and Africa Etodolac Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Etodolac Sales by Type (2019-2030)
4.1.1 Global Etodolac Sales by Type (2019-2024)
4.1.2 Global Etodolac Sales by Type (2025-2030)
4.1.3 Global Etodolac Sales Market Share by Type (2019-2030)
4.2 Global Etodolac Revenue by Type (2019-2030)
4.2.1 Global Etodolac Revenue by Type (2019-2024)
4.2.2 Global Etodolac Revenue by Type (2025-2030)
4.2.3 Global Etodolac Revenue Market Share by Type (2019-2030)
4.3 Global Etodolac Price by Type (2019-2030)
5 Segment by Application
5.1 Global Etodolac Sales by Application (2019-2030)
5.1.1 Global Etodolac Sales by Application (2019-2024)
5.1.2 Global Etodolac Sales by Application (2025-2030)
5.1.3 Global Etodolac Sales Market Share by Application (2019-2030)
5.2 Global Etodolac Revenue by Application (2019-2030)
5.2.1 Global Etodolac Revenue by Application (2019-2024)
5.2.2 Global Etodolac Revenue by Application (2025-2030)
5.2.3 Global Etodolac Revenue Market Share by Application (2019-2030)
5.3 Global Etodolac Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amneal Pharmaceuticals
6.1.1 Amneal Pharmaceuticals Corporation Information
6.1.2 Amneal Pharmaceuticals Description and Business Overview
6.1.3 Amneal Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amneal Pharmaceuticals Etodolac Product Portfolio
6.1.5 Amneal Pharmaceuticals Recent Developments/Updates
6.2 Genpharm Ulc
6.2.1 Genpharm Ulc Corporation Information
6.2.2 Genpharm Ulc Description and Business Overview
6.2.3 Genpharm Ulc Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Genpharm Ulc Etodolac Product Portfolio
6.2.5 Genpharm Ulc Recent Developments/Updates
6.3 Physicians Total Care
6.3.1 Physicians Total Care Corporation Information
6.3.2 Physicians Total Care Description and Business Overview
6.3.3 Physicians Total Care Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Physicians Total Care Etodolac Product Portfolio
6.3.5 Physicians Total Care Recent Developments/Updates
6.4 Actavis Elizabeth
6.4.1 Actavis Elizabeth Corporation Information
6.4.2 Actavis Elizabeth Description and Business Overview
6.4.3 Actavis Elizabeth Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Actavis Elizabeth Etodolac Product Portfolio
6.4.5 Actavis Elizabeth Recent Developments/Updates
6.5 Blenheim Pharmacal
6.5.1 Blenheim Pharmacal Corporation Information
6.5.2 Blenheim Pharmacal Description and Business Overview
6.5.3 Blenheim Pharmacal Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Blenheim Pharmacal Etodolac Product Portfolio
6.5.5 Blenheim Pharmacal Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Etodolac Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Taro Pharmaceuticals
6.6.1 Taro Pharmaceuticals Corporation Information
6.6.2 Taro Pharmaceuticals Description and Business Overview
6.6.3 Taro Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Taro Pharmaceuticals Etodolac Product Portfolio
6.7.5 Taro Pharmaceuticals Recent Developments/Updates
6.8 Apotex
6.8.1 Apotex Corporation Information
6.8.2 Apotex Description and Business Overview
6.8.3 Apotex Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Apotex Etodolac Product Portfolio
6.8.5 Apotex Recent Developments/Updates
6.9 PD-Rx Pharmaceuticals
6.9.1 PD-Rx Pharmaceuticals Corporation Information
6.9.2 PD-Rx Pharmaceuticals Description and Business Overview
6.9.3 PD-Rx Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PD-Rx Pharmaceuticals Etodolac Product Portfolio
6.9.5 PD-Rx Pharmaceuticals Recent Developments/Updates
6.10 Nucare Pharmaceuticals
6.10.1 Nucare Pharmaceuticals Corporation Information
6.10.2 Nucare Pharmaceuticals Description and Business Overview
6.10.3 Nucare Pharmaceuticals Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nucare Pharmaceuticals Etodolac Product Portfolio
6.10.5 Nucare Pharmaceuticals Recent Developments/Updates
6.11 Eon Labs
6.11.1 Eon Labs Corporation Information
6.11.2 Eon Labs Etodolac Description and Business Overview
6.11.3 Eon Labs Etodolac Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eon Labs Etodolac Product Portfolio
6.11.5 Eon Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Etodolac Industry Chain Analysis
7.2 Etodolac Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Etodolac Production Mode & Process
7.4 Etodolac Sales and Marketing
7.4.1 Etodolac Sales Channels
7.4.2 Etodolac Distributors
7.5 Etodolac Customers
8 Etodolac Market Dynamics
8.1 Etodolac Industry Trends
8.2 Etodolac Market Drivers
8.3 Etodolac Market Challenges
8.4 Etodolac Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Etodolac Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Etodolac Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Etodolac Market Competitive Situation by Manufacturers in 2023
Table 4. Global Etodolac Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Etodolac Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Etodolac Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Etodolac Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Etodolac Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Etodolac, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Etodolac, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Etodolac, Product Type & Application
Table 12. Global Key Manufacturers of Etodolac, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Etodolac by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Etodolac as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Etodolac Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Etodolac Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Etodolac Sales Market Share by Region (2019-2024)
Table 19. Global Etodolac Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Etodolac Sales Market Share by Region (2025-2030)
Table 21. Global Etodolac Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Etodolac Revenue Market Share by Region (2019-2024)
Table 23. Global Etodolac Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Etodolac Revenue Market Share by Region (2025-2030)
Table 25. North America Etodolac Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Etodolac Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Etodolac Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Etodolac Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Etodolac Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Etodolac Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Etodolac Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Etodolac Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Etodolac Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Etodolac Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Etodolac Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Etodolac Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Etodolac Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Etodolac Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Etodolac Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Etodolac Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Etodolac Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Etodolac Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Etodolac Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Etodolac Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Etodolac Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Etodolac Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Etodolac Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Etodolac Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Etodolac Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Etodolac Sales (K Pcs) by Type (2019-2024)
Table 51. Global Etodolac Sales (K Pcs) by Type (2025-2030)
Table 52. Global Etodolac Sales Market Share by Type (2019-2024)
Table 53. Global Etodolac Sales Market Share by Type (2025-2030)
Table 54. Global Etodolac Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Etodolac Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Etodolac Revenue Market Share by Type (2019-2024)
Table 57. Global Etodolac Revenue Market Share by Type (2025-2030)
Table 58. Global Etodolac Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Etodolac Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Etodolac Sales (K Pcs) by Application (2019-2024)
Table 61. Global Etodolac Sales (K Pcs) by Application (2025-2030)
Table 62. Global Etodolac Sales Market Share by Application (2019-2024)
Table 63. Global Etodolac Sales Market Share by Application (2025-2030)
Table 64. Global Etodolac Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Etodolac Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Etodolac Revenue Market Share by Application (2019-2024)
Table 67. Global Etodolac Revenue Market Share by Application (2025-2030)
Table 68. Global Etodolac Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Etodolac Price (USD/Pcs) by Application (2025-2030)
Table 70. Amneal Pharmaceuticals Corporation Information
Table 71. Amneal Pharmaceuticals Description and Business Overview
Table 72. Amneal Pharmaceuticals Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Amneal Pharmaceuticals Etodolac Product
Table 74. Amneal Pharmaceuticals Recent Developments/Updates
Table 75. Genpharm Ulc Corporation Information
Table 76. Genpharm Ulc Description and Business Overview
Table 77. Genpharm Ulc Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Genpharm Ulc Etodolac Product
Table 79. Genpharm Ulc Recent Developments/Updates
Table 80. Physicians Total Care Corporation Information
Table 81. Physicians Total Care Description and Business Overview
Table 82. Physicians Total Care Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Physicians Total Care Etodolac Product
Table 84. Physicians Total Care Recent Developments/Updates
Table 85. Actavis Elizabeth Corporation Information
Table 86. Actavis Elizabeth Description and Business Overview
Table 87. Actavis Elizabeth Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Actavis Elizabeth Etodolac Product
Table 89. Actavis Elizabeth Recent Developments/Updates
Table 90. Blenheim Pharmacal Corporation Information
Table 91. Blenheim Pharmacal Description and Business Overview
Table 92. Blenheim Pharmacal Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Blenheim Pharmacal Etodolac Product
Table 94. Blenheim Pharmacal Recent Developments/Updates
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Teva Etodolac Product
Table 99. Teva Recent Developments/Updates
Table 100. Taro Pharmaceuticals Corporation Information
Table 101. Taro Pharmaceuticals Description and Business Overview
Table 102. Taro Pharmaceuticals Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Taro Pharmaceuticals Etodolac Product
Table 104. Taro Pharmaceuticals Recent Developments/Updates
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Business Overview
Table 107. Apotex Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Apotex Etodolac Product
Table 109. Apotex Recent Developments/Updates
Table 110. PD-Rx Pharmaceuticals Corporation Information
Table 111. PD-Rx Pharmaceuticals Description and Business Overview
Table 112. PD-Rx Pharmaceuticals Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. PD-Rx Pharmaceuticals Etodolac Product
Table 114. PD-Rx Pharmaceuticals Recent Developments/Updates
Table 115. Nucare Pharmaceuticals Corporation Information
Table 116. Nucare Pharmaceuticals Description and Business Overview
Table 117. Nucare Pharmaceuticals Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Nucare Pharmaceuticals Etodolac Product
Table 119. Nucare Pharmaceuticals Recent Developments/Updates
Table 120. Eon Labs Corporation Information
Table 121. Eon Labs Description and Business Overview
Table 122. Eon Labs Etodolac Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Eon Labs Etodolac Product
Table 124. Eon Labs Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Etodolac Distributors List
Table 128. Etodolac Customers List
Table 129. Etodolac Market Trends
Table 130. Etodolac Market Drivers
Table 131. Etodolac Market Challenges
Table 132. Etodolac Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Etodolac
Figure 2. Global Etodolac Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Etodolac Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Etodolac Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Etodolac Market Share by Application in 2023 & 2030
Figure 8. Rheumatoid Arthritis
Figure 9. Osteoarthritis
Figure 10. Mild to Moderate Pain
Figure 11. Others
Figure 12. Global Etodolac Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Etodolac Market Size (2019-2030) & (US$ Million)
Figure 14. Global Etodolac Sales (2019-2030) & (K Pcs)
Figure 15. Global Etodolac Average Price (USD/Pcs) & (2019-2030)
Figure 16. Etodolac Report Years Considered
Figure 17. Etodolac Sales Share by Manufacturers in 2023
Figure 18. Global Etodolac Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Etodolac Players: Market Share by Revenue in 2023
Figure 20. Etodolac Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Etodolac Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Etodolac Sales Market Share by Country (2019-2030)
Figure 23. North America Etodolac Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Etodolac Sales Market Share by Country (2019-2030)
Figure 27. Europe Etodolac Revenue Market Share by Country (2019-2030)
Figure 28. Germany Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Etodolac Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Etodolac Revenue Market Share by Region (2019-2030)
Figure 35. China Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Etodolac Sales Market Share by Country (2019-2030)
Figure 46. Latin America Etodolac Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Etodolac Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Etodolac Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Etodolac Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Etodolac by Type (2019-2030)
Figure 56. Global Revenue Market Share of Etodolac by Type (2019-2030)
Figure 57. Global Etodolac Price (USD/Pcs) by Type (2019-2030)
Figure 58. Global Sales Market Share of Etodolac by Application (2019-2030)
Figure 59. Global Revenue Market Share of Etodolac by Application (2019-2030)
Figure 60. Global Etodolac Price (USD/Pcs) by Application (2019-2030)
Figure 61. Etodolac Value Chain
Figure 62. Etodolac Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
